LUNG
Pulmonx Corporation
Price Chart
Latest Quote
$1.39
+0.11 (+8.59%)
Current Price
| Previous Close | $1.28 |
| Open | $1.26 |
| Day High | $1.42 |
| Day Low | $1.26 |
| Volume | 571,717 |
Stock Information
| Shares Outstanding | 42.24M |
| Total Debt | $56.29M |
| Cash Equivalents | $61.57M |
| Revenue | $88.55M |
| Net Income | $-53.21M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $58.71M |
| EPS (TTM) | $-1.30 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $53.43M |
| Sales | $88.55M |
| Income | $-53.21M |
| Book/sh | $1.08 |
| Cash/sh | $1.46 |
| Employees | 296 |
Financial Ratios
| Quick Ratio | 3.85 |
| Current Ratio | 4.91 |
| Debt/Eq | 123.02 |
Returns & Margins
| ROA | -24.04% |
| ROE | -86.22% |
| Gross Margin | 75.49% |
| Operating Margin | -62.94% |
| Profit Margin | -60.09% |
Ownership
| Insider Ownership | 4.89% |
| Institutional Ownership | 79.11% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.33 |
| P/S | 0.66 |
| P/B | 1.28 |
Analyst Data
| Recommendation | none |
| Target Price | $3.40 |
Technical Indicators
| SMA20 | $1.45 |
| SMA50 | $1.39 |
| SMA200 | $1.65 |
| RSI | 40.85 |
| ATR | 0.1076 |
| Shares Float | 36.97M |
| Short Float | 7.92% |
| Short Ratio | 5.22 |
| Volatility | 0.28 |
| Rel Volume | 1.56 |
Performance History
| Week | +11.20% |
| Month | -10.32% |
| Quarter | +6.11% |
| 6 Months | -46.54% |
| YTD | -39.57% |
| Year | -45.91% |
| 3 Years | -88.99% |
| 5 Years | -96.76% |
| 10 Years | -96.46% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $1.39 | 571,800 |
| 2026-06-23 | $1.28 | 399,800 |
| 2026-06-22 | $1.27 | 452,200 |
| 2026-06-18 | $1.28 | 619,900 |
| 2026-06-17 | $1.25 | 293,300 |
| 2026-06-16 | $1.25 | 610,600 |
| 2026-06-15 | $1.28 | 751,300 |
| 2026-06-12 | $1.37 | 226,100 |
| 2026-06-11 | $1.42 | 303,200 |
| 2026-06-10 | $1.43 | 340,700 |
| 2026-06-09 | $1.53 | 276,500 |
| 2026-06-08 | $1.49 | 107,100 |
| 2026-06-05 | $1.53 | 154,000 |
| 2026-06-04 | $1.62 | 165,400 |
| 2026-06-03 | $1.52 | 408,600 |
| 2026-06-02 | $1.61 | 201,800 |
| 2026-06-01 | $1.59 | 551,500 |
| 2026-05-29 | $1.65 | 290,500 |
| 2026-05-28 | $1.68 | 299,000 |
| 2026-05-27 | $1.54 | 330,300 |
| 2026-05-26 | $1.57 | 478,400 |
About Pulmonx Corporation
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
đ° Latest News
Pulmonx (LUNG) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-04-30T16:25:20Z
Pulmonx Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-04-30T12:30:00Z
Pulmonx Corp (LUNG) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
GuruFocus.com âĸ 2026-04-30T07:17:30ZPulmonx Q1 Earnings Call Highlights
MarketBeat âĸ 2026-04-29T21:50:17Z
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-04-29T21:45:06Z
How The Pulmonx (LUNG) Investment Narrative Is Resetting Around A Lower Target And Execution Risk
Simply Wall St. âĸ 2026-04-19T15:05:30Z
Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?
Zacks âĸ 2026-04-17T10:22:00Z
How The Pulmonx (LUNG) Investment Story Is Shifting After Q4 And New Guidance
Simply Wall St. âĸ 2026-04-05T00:17:56Z
TruBridge (TBRG) Beats Q4 Earnings Estimates
Zacks âĸ 2026-03-31T21:25:02Z
How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions
Simply Wall St. âĸ 2026-03-21T05:02:59Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $23,358,000 | $21,788,000 | $17,923,000 | $13,797,000 |
| Cost Of Revenue | $23,358,000 | $21,788,000 | $17,923,000 | $13,797,000 |
| Total Revenue | $90,497,000 | $83,789,000 | $68,675,000 | $53,662,000 |
| Operating Revenue | $90,497,000 | $83,789,000 | $68,675,000 | $53,662,000 |
| Expenses | ||||
| Interest Expense | $3,155,000 | $3,507,000 | $3,232,000 | $1,066,000 |
| Total Expenses | $144,160,000 | $141,493,000 | $130,610,000 | $112,299,000 |
| Other Income Expense | $790,000 | $256,000 | $-673,000 | $-396,000 |
| Other Non Operating Income Expenses | $790,000 | $256,000 | $-673,000 | $-396,000 |
| Net Non Operating Interest Income Expense | $-504,000 | $1,554,000 | $2,336,000 | $463,000 |
| Interest Expense Non Operating | $3,155,000 | $3,507,000 | $3,232,000 | $1,066,000 |
| Operating Expense | $120,802,000 | $119,705,000 | $112,687,000 | $98,502,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Net Interest Income | $-504,000 | $1,554,000 | $2,336,000 | $463,000 |
| Interest Income | $2,651,000 | $5,061,000 | $5,568,000 | $1,529,000 |
| Normalized Income | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Net Income From Continuing And Discontinued Operation | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Total Operating Income As Reported | $-53,663,000 | $-57,704,000 | $-61,935,000 | $-58,637,000 |
| Net Income Common Stockholders | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Net Income | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Net Income Including Noncontrolling Interests | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Net Income Continuous Operations | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Pretax Income | $-53,377,000 | $-55,894,000 | $-60,272,000 | $-58,570,000 |
| Interest Income Non Operating | $2,651,000 | $5,061,000 | $5,568,000 | $1,529,000 |
| Operating Income | $-53,663,000 | $-57,704,000 | $-61,935,000 | $-58,637,000 |
| Gross Profit | $67,139,000 | $62,001,000 | $50,752,000 | $39,865,000 |
| Per Share | ||||
| Diluted EPS | $-1.33 | $-1.44 | $-1.60 | $-1.59 |
| Basic EPS | $-1.33 | $-1.44 | $-1.60 | $-1.59 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-49,168,000 | $-50,894,000 | $-55,492,000 | $-55,991,000 |
| Reconciled Depreciation | $1,054,000 | $1,493,000 | $1,548,000 | $1,513,000 |
| EBITDA (Bullshit earnings) | $-49,168,000 | $-50,894,000 | $-55,492,000 | $-55,991,000 |
| EBIT | $-50,222,000 | $-52,387,000 | $-57,040,000 | $-57,504,000 |
| Diluted Average Shares | $40,685,934 | $39,111,073 | $37,974,567 | $37,096,541 |
| Basic Average Shares | $40,685,934 | $39,111,073 | $37,974,567 | $37,096,541 |
| Diluted NI Availto Com Stockholders | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Tax Provision | $626,000 | $500,000 | $571,000 | $353,000 |
| Research And Development | $19,491,000 | $17,570,000 | $18,080,000 | $15,397,000 |
| Selling General And Administration | $101,311,000 | $102,135,000 | $94,607,000 | $83,105,000 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $51,783,000 | $83,476,000 | $115,951,000 | $151,520,000 |
| Total Assets | $129,291,000 | $162,850,000 | $177,781,000 | $193,676,000 |
| Total Non Current Assets | $27,607,000 | $26,602,000 | $27,359,000 | $24,723,000 |
| Other Non Current Assets | $5,026,000 | $2,817,000 | $3,171,000 | $5,812,000 |
| Goodwill And Other Intangible Assets | $2,333,000 | $2,333,000 | $2,364,000 | $2,487,000 |
| Current Assets | $101,684,000 | $136,248,000 | $150,422,000 | $168,953,000 |
| Other Current Assets | $491,000 | $1,129,000 | $504,000 | $290,000 |
| Restricted Cash | $258,000 | $257,000 | $237,000 | $231,000 |
| Prepaid Assets | $2,676,000 | $2,674,000 | $2,816,000 | $3,451,000 |
| Inventory | $15,845,000 | $16,915,000 | $16,743,000 | $14,564,000 |
| Receivables | $12,663,000 | $13,791,000 | $13,020,000 | $9,279,000 |
| Taxes Receivable | $591,000 | $671,000 | $915,000 | $602,000 |
| Accounts Receivable | $12,072,000 | $13,120,000 | $12,105,000 | $8,677,000 |
| Allowance For Doubtful Accounts Receivable | $-100,000 | $-100,000 | $0 | $-100,000 |
| Gross Accounts Receivable | $12,172,000 | $13,220,000 | $12,105,000 | $8,777,000 |
| Cash Cash Equivalents And Short Term Investments | $69,751,000 | $101,482,000 | $117,102,000 | $141,138,000 |
| Cash And Cash Equivalents | $69,751,000 | $70,905,000 | $83,547,000 | $101,736,000 |
| Cash Equivalents | $1,038,000 | $6,616,000 | $25,129,000 | $4,647,000 |
| Cash Financial | $68,713,000 | $64,289,000 | $58,418,000 | $97,089,000 |
| Investmentin Financial Assets | - | $0 | $14,390,000 | $5,924,000 |
| Other Intangible Assets | - | - | $31,000 | $154,000 |
| Debt | ||||
| Total Debt | $56,364,000 | $56,471,000 | $41,424,000 | $24,402,000 |
| Long Term Debt And Capital Lease Obligation | $55,048,000 | $52,517,000 | $36,195,000 | $21,083,000 |
| Long Term Debt | $36,989,000 | $34,002,000 | $35,089,000 | $17,234,000 |
| Current Debt And Capital Lease Obligation | $1,316,000 | $3,954,000 | $5,229,000 | $3,319,000 |
| Current Debt | $106,000 | $3,176,000 | $2,155,000 | $90,000 |
| Other Current Borrowings | $106,000 | $3,176,000 | $2,155,000 | $90,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $75,175,000 | $77,041,000 | $59,466,000 | $39,669,000 |
| Total Non Current Liabilities Net Minority Interest | $55,117,000 | $52,604,000 | $36,309,000 | $21,177,000 |
| Non Current Deferred Liabilities | $69,000 | $87,000 | $114,000 | $94,000 |
| Non Current Deferred Taxes Liabilities | $69,000 | $87,000 | $114,000 | $94,000 |
| Current Liabilities | $20,058,000 | $24,437,000 | $23,157,000 | $18,492,000 |
| Current Deferred Liabilities | $18,000 | $135,000 | $104,000 | $120,000 |
| Payables And Accrued Expenses | $15,175,000 | $13,454,000 | $9,949,000 | $10,080,000 |
| Payables | $5,179,000 | $4,703,000 | $2,353,000 | $2,404,000 |
| Total Tax Payable | $1,274,000 | $876,000 | $856,000 | $646,000 |
| Income Tax Payable | $263,000 | $49,000 | $93,000 | $19,000 |
| Accounts Payable | $3,905,000 | $3,827,000 | $1,497,000 | $1,758,000 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $54,116,000 | $85,809,000 | $118,315,000 | $154,007,000 |
| Total Equity Gross Minority Interest | $54,116,000 | $85,809,000 | $118,315,000 | $154,007,000 |
| Stockholders Equity | $54,116,000 | $85,809,000 | $118,315,000 | $154,007,000 |
| Gains Losses Not Affecting Retained Earnings | $2,360,000 | $2,113,000 | $2,640,000 | $1,575,000 |
| Other Equity Adjustments | $2,360,000 | $2,113,000 | $2,640,000 | $1,575,000 |
| Retained Earnings | $-521,558,000 | $-467,555,000 | $-411,161,000 | $-350,318,000 |
| Other | ||||
| Ordinary Shares Number | $41,673,648 | $39,785,969 | $38,516,383 | $37,555,565 |
| Share Issued | $41,673,648 | $39,785,969 | $38,516,383 | $37,555,565 |
| Tangible Book Value | $51,783,000 | $83,476,000 | $115,951,000 | $151,520,000 |
| Invested Capital | $91,211,000 | $122,987,000 | $155,559,000 | $171,331,000 |
| Working Capital | $81,626,000 | $111,811,000 | $127,265,000 | $150,461,000 |
| Capital Lease Obligations | $19,269,000 | $19,293,000 | $4,180,000 | $7,078,000 |
| Total Capitalization | $91,105,000 | $119,811,000 | $153,404,000 | $171,241,000 |
| Additional Paid In Capital | $573,272,000 | $551,211,000 | $526,797,000 | $502,712,000 |
| Capital Stock | $42,000 | $40,000 | $39,000 | $38,000 |
| Common Stock | $42,000 | $40,000 | $39,000 | $38,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $18,059,000 | $18,515,000 | $1,106,000 | $3,849,000 |
| Current Deferred Revenue | $18,000 | $135,000 | $104,000 | $120,000 |
| Current Capital Lease Obligation | $1,210,000 | $778,000 | $3,074,000 | $3,229,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $3,549,000 | $6,894,000 | $7,875,000 | $4,973,000 |
| Current Accrued Expenses | $9,996,000 | $8,751,000 | $7,596,000 | $7,676,000 |
| Goodwill | $2,333,000 | $2,333,000 | $2,333,000 | $2,333,000 |
| Net PPE | $20,248,000 | $21,452,000 | $7,434,000 | $10,500,000 |
| Accumulated Depreciation | $-6,650,000 | $-5,724,000 | $-4,855,000 | $-3,556,000 |
| Gross PPE | $26,898,000 | $27,176,000 | $12,289,000 | $14,056,000 |
| Leases | $2,336,000 | $2,318,000 | $2,277,000 | $2,277,000 |
| Construction In Progress | $51,000 | $206,000 | $2,199,000 | $1,825,000 |
| Other Properties | $18,028,000 | $18,545,000 | $3,406,000 | $5,806,000 |
| Machinery Furniture Equipment | $6,483,000 | $6,107,000 | $4,407,000 | $4,148,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $0 | $30,577,000 | $33,555,000 | $39,402,000 |
| Investments And Advances | - | $0 | $14,390,000 | $5,924,000 |
| Available For Sale Securities | - | - | $14,390,000 | $5,924,000 |
| Finished Goods | - | - | - | - |
| Work In Process | - | - | - | - |
| Raw Materials | - | - | - | - |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-32,828,000 | $-32,984,000 | $-38,417,000 | $-46,401,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-32,376,000 | $-31,537,000 | $-37,610,000 | $-45,083,000 |
| Cash Flow From Continuing Operating Activities | $-32,376,000 | $-31,537,000 | $-37,610,000 | $-45,083,000 |
| Operating Gains Losses | - | - | $-15,000 | $7,000 |
| Investing Activities | ||||
| Capital Expenditure | $-452,000 | $-1,447,000 | $-807,000 | $-1,318,000 |
| Investing Cash Flow | $30,482,000 | $17,476,000 | $-2,007,000 | $-4,225,000 |
| Cash Flow From Continuing Investing Activities | $30,482,000 | $17,476,000 | $-2,007,000 | $-4,225,000 |
| Financing Activities | ||||
| Financing Cash Flow | $833,000 | $1,363,000 | $21,400,000 | $2,419,000 |
| Cash Flow From Continuing Financing Activities | $833,000 | $1,363,000 | $21,400,000 | $2,419,000 |
| Net Other Financing Charges | $-70,000 | - | - | $-53,000 |
| Issuance Of Capital Stock | - | - | - | - |
| Net Common Stock Issuance | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-100,000 | $-95,000 | $-94,000 | $-87,000 |
| Interest Paid Supplemental Data | $3,113,000 | $3,482,000 | $2,984,000 | $847,000 |
| Income Tax Paid Supplemental Data | $468,000 | $556,000 | $471,000 | $398,000 |
| End Cash Position | $70,009,000 | $71,162,000 | $83,784,000 | $101,967,000 |
| Beginning Cash Position | $71,162,000 | $83,784,000 | $101,967,000 | $148,711,000 |
| Effect Of Exchange Rate Changes | $-92,000 | $76,000 | $34,000 | $145,000 |
| Changes In Cash | $-1,061,000 | $-12,698,000 | $-18,217,000 | $-46,889,000 |
| Proceeds From Stock Option Exercised | $1,003,000 | $1,458,000 | $1,494,000 | $2,559,000 |
| Net Issuance Payments Of Debt | $-100,000 | $-95,000 | $19,906,000 | $-87,000 |
| Net Long Term Debt Issuance | $-100,000 | $-95,000 | $19,906,000 | $-87,000 |
| Long Term Debt Payments | $-100,000 | $-95,000 | $-94,000 | $-87,000 |
| Net Investment Purchase And Sale | $30,934,000 | $18,923,000 | $-1,200,000 | $-2,907,000 |
| Sale Of Investment | $36,585,000 | $46,837,000 | $45,000,000 | $44,280,000 |
| Purchase Of Investment | $-5,651,000 | $-27,914,000 | $-46,200,000 | $-47,187,000 |
| Net PPE Purchase And Sale | $-452,000 | $-1,447,000 | $-807,000 | $-1,318,000 |
| Purchase Of PPE | $-452,000 | $-1,447,000 | $-807,000 | $-1,318,000 |
| Change In Working Capital | $-1,925,000 | $-1,703,000 | $-2,558,000 | $-7,014,000 |
| Change In Other Working Capital | $-136,000 | $-16,000 | $4,000 | $8,000 |
| Change In Other Current Liabilities | $-955,000 | $-1,870,000 | $-3,182,000 | $-2,197,000 |
| Change In Other Current Assets | $-142,000 | $-546,000 | $-36,000 | $-49,000 |
| Change In Payables And Accrued Expense | $-1,815,000 | $2,702,000 | $2,899,000 | $272,000 |
| Change In Accrued Expense | $-2,279,000 | $462,000 | $3,176,000 | $149,000 |
| Change In Payable | $464,000 | $2,240,000 | $-277,000 | $123,000 |
| Change In Account Payable | $270,000 | $2,278,000 | $-345,000 | $247,000 |
| Change In Tax Payable | $194,000 | $-38,000 | $68,000 | $-124,000 |
| Change In Income Tax Payable | $194,000 | $-38,000 | $68,000 | $-124,000 |
| Change In Prepaid Assets | $813,000 | $-436,000 | $-57,000 | $780,000 |
| Change In Inventory | $-765,000 | $-229,000 | $918,000 | $-3,638,000 |
| Change In Receivables | $1,075,000 | $-1,308,000 | $-3,104,000 | $-2,190,000 |
| Changes In Account Receivables | $1,075,000 | $-1,308,000 | $-3,104,000 | $-2,190,000 |
| Other Non Cash Items | $1,501,000 | $1,896,000 | $2,734,000 | $2,554,000 |
| Stock Based Compensation | $21,233,000 | $22,955,000 | $22,101,000 | $16,445,000 |
| Provisionand Write Offof Assets | $0 | $40,000 | $-59,000 | $54,000 |
| Asset Impairment Charge | $143,000 | $1,792,000 | $507,000 | $485,000 |
| Amortization Of Securities | $-379,000 | $-1,616,000 | $-1,025,000 | $-204,000 |
| Depreciation Amortization Depletion | $1,054,000 | $1,493,000 | $1,548,000 | $1,513,000 |
| Depreciation And Amortization | $1,054,000 | $1,493,000 | $1,548,000 | $1,513,000 |
| Net Income From Continuing Operations | $-54,003,000 | $-56,394,000 | $-60,843,000 | $-58,923,000 |
| Issuance Of Debt | - | $0 | $20,000,000 | $0 |
| Long Term Debt Issuance | - | $0 | $20,000,000 | $0 |
| Gain Loss On Sale Of PPE | - | $0 | $-15,000 | $7,000 |
Fetched: 2026-06-23